About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
BNF Category
1: Gastro-intestinal system
2: Cardiovascular system
3: Respiratory system
4: Central nervous system
5: Infections
6: Endocrine system
7: Obstetrics, gynaecology, and urinary-tract disorders
8: Malignant disease and immunosuppression
9: Nutrition and blood
10: Musculoskeletal and joint diseases
11: Eye
12: Ear, nose, and oropharynx
13: Skin
14: Immunological products and vaccines
15: Anaesthesia
Appendix 7
Appendix 8 Wound management products and elasticated garments
Non-BNF miscellaneous
Emergency treatment of poisoning
9.1 Anaemias and some other blood disorders
9.2 Fluids and electrolytes
9.3 Intravenous nutrition
9.4 Oral nutrition
9.5 Minerals
9.6 Vitamins
9.7 Bitters and tonics
9.8 Metabolic disorders
9.5.1 Calcium and magnesium
9.5.2 Phosphorus
9.5.3 Fluoride
9.5.4 Zinc
9.5.5 Selenium
36 library items
in 9.5.2 Phosphorus
Filter results by:
Date Published
2012 (1)
2011 (4)
2010 (10)
2009 (5)
2008 (2)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
9: Nutrition and blood (
remove
)
,
9.5 Minerals (
remove
)
,
9.5.2 Phosphorus (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 36
Result page:
Previous
|
1
2
3
4
|
Next
1.
Nurse-led education and counselling to enhance adherence to phosphate binders
Source:
Journal of Clinical Nursing
,
Date published:
23/04/2012
Category:
9.5.2 Phosphorus
|
Compliance
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
2.
SMC accepts sevelamer carbonate (Renvela®) for restricted use in the treatment of hyperphosphataemia in adults receiving haemodialysis
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
12/04/2011
Category:
9.5.2 Phosphorus
|
Drug reviews
|
Nutrition and Metabolism
|
Renal medicine
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
3.
SMC does not recommend calcium acetate and magnesium carbonate (Osvaren®) for hyperphosphataemia in dialysis patients
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
12/04/2011
Category:
9.5.2 Phosphorus
|
Drug reviews
|
Nutrition and Metabolism
|
Renal medicine
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Drug advice
4.
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Source:
Cochrane Database of Systematic Reviews
,
Date published:
30/03/2011
Category:
9.5.2 Phosphorus
|
Drug reviews
|
Renal medicine
NeLM
Area:
Evidence
>
Drug Class Focused Reviews
Link to Abstract
5.
Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: an analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada
Source:
American Journal of Kidney Diseases
,
Date published:
25/01/2011
Category:
9.5.2 Phosphorus
|
Prescribing and supply of medicines
|
Renal medicine
NeLM
Area:
Evidence
>
Medicines Management
>
References
Full text link
6.
Updated national IV monograph on Phosphate Polyfusor/Freeflex
Source:
Medusa
,
Date published:
12/11/2010
Category:
9.5.2 Phosphorus
|
Drug Administration
NeLM
Area:
News
Link- registration required
Link to questions and answers document
7.
SMC does not recommend sevelamer carbonate (Renvela®) for hyperphosphataemia in adults receiving haemodialysis or peritoneal dialysis
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
09/11/2010
Category:
9.5.2 Phosphorus
|
Drug reviews
|
Drugs in renal failure
|
Renal medicine
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
8.
Off-label use of phosphate binders in non-dialysis-dependent CKD
Source:
American Journal of Kidney Diseases
,
Date published:
28/10/2010
Category:
9.5.2 Phosphorus
|
Food &Drug Administration (FDA)
NeLM
Area:
Evidence
>
Medicines Management
>
References
Full text link
9.
SMC does not recommend lanthanum carbonate (Fosrenol®) for hyperphosphataemia in adults with CKD not on dialysis
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
12/10/2010
Category:
9.5.2 Phosphorus
|
Clinical guidelines
|
Renal medicine
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
10.
Renvela® (sevelamer carbonate) launched in the UK
Source:
PharmaTimes
,
Date published:
06/10/2010
Category:
9.5.2 Phosphorus
|
New drugs
|
Renal medicine
NeLM
Area:
News
Link
SPC (film-coated tablets)
SPC (powder for oral suspension)
Results 1 - 10 of 36
Result page:
Previous
|
1
2
3
4
|
Next